Ling et al. found that the potential mechanism by which CC inhibited the metastasis of MDA-MB-231 mammary cancer cells was AKT- and JNK1/2-mediated NF-κB signaling pathways, and this treatment was accompanied by decreased MMP9 expression (19). Here, NFKB1 is linked to breast cancer.